GlassScriptPhysician profile
Genevieve Groff
NPI 1578706248
$5,878.70
in general payments reported to CMS, 2019-2025
49 companies · $1,429 in 2025
The $1,429 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $730 · 2022: $1,239 · 2023: $1,096 · 2024: $1,384 · 2025: $1,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,892 · Entertainment: $17.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,891.63 |
| Entertainment | $17.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,170.93 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $622.35 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $462.01 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $421.06 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $368.91 | 2021-2024 | Jardiance |
| Glaxosmithkline, LLC. | $312.14 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $198.86 | 2023-2025 | |
| Eisai INC. | $185.20 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $170.15 | 2022-2025 | |
| Amgen INC. | $136.83 | 2024-2025 | Krystexxa, Repatha, Otezla |
| Abbott Laboratories | $130.87 | 2021-2025 | Freestyle Libre 3, Confirm Rx, Proclaim |
| Takeda Pharmaceuticals U.S.A., INC. | $125.00 | 2021-2022 | |
| Dexcom, INC. | $123.46 | 2022-2025 | Dexcom G6 Transmitter |
| Lucid Diagnostics INC. | $116.34 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $110.79 | 2022-2023 | Hetlioz |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Genevieve Groff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.